1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD20 Target Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for CD20 Target Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for CD20 Target Drug by Country/Region, 2018, 2022 & 2029
2.2 CD20 Target Drug Segment by Type
2.2.1 CD20 Target
2.2.2 CD20+CD3 Target
2.3 CD20 Target Drug Sales by Type
2.3.1 Global CD20 Target Drug Sales Market Share by Type (2018-2023)
2.3.2 Global CD20 Target Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global CD20 Target Drug Sale Price by Type (2018-2023)
2.4 CD20 Target Drug Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Chronic Lymphocytic Leukemia
2.4.3 Lymphoma
2.4.4 Other
2.5 CD20 Target Drug Sales by Application
2.5.1 Global CD20 Target Drug Sale Market Share by Application (2018-2023)
2.5.2 Global CD20 Target Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global CD20 Target Drug Sale Price by Application (2018-2023)
3 Global CD20 Target Drug by Company
3.1 Global CD20 Target Drug Breakdown Data by Company
3.1.1 Global CD20 Target Drug Annual Sales by Company (2018-2023)
3.1.2 Global CD20 Target Drug Sales Market Share by Company (2018-2023)
3.2 Global CD20 Target Drug Annual Revenue by Company (2018-2023)
3.2.1 Global CD20 Target Drug Revenue by Company (2018-2023)
3.2.2 Global CD20 Target Drug Revenue Market Share by Company (2018-2023)
3.3 Global CD20 Target Drug Sale Price by Company
3.4 Key Manufacturers CD20 Target Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD20 Target Drug Product Location Distribution
3.4.2 Players CD20 Target Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for CD20 Target Drug by Geographic Region
4.1 World Historic CD20 Target Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global CD20 Target Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global CD20 Target Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic CD20 Target Drug Market Size by Country/Region (2018-2023)
4.2.1 Global CD20 Target Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global CD20 Target Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas CD20 Target Drug Sales Growth
4.4 APAC CD20 Target Drug Sales Growth
4.5 Europe CD20 Target Drug Sales Growth
4.6 Middle East & Africa CD20 Target Drug Sales Growth
5 Americas
5.1 Americas CD20 Target Drug Sales by Country
5.1.1 Americas CD20 Target Drug Sales by Country (2018-2023)
5.1.2 Americas CD20 Target Drug Revenue by Country (2018-2023)
5.2 Americas CD20 Target Drug Sales by Type
5.3 Americas CD20 Target Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD20 Target Drug Sales by Region
6.1.1 APAC CD20 Target Drug Sales by Region (2018-2023)
6.1.2 APAC CD20 Target Drug Revenue by Region (2018-2023)
6.2 APAC CD20 Target Drug Sales by Type
6.3 APAC CD20 Target Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe CD20 Target Drug by Country
7.1.1 Europe CD20 Target Drug Sales by Country (2018-2023)
7.1.2 Europe CD20 Target Drug Revenue by Country (2018-2023)
7.2 Europe CD20 Target Drug Sales by Type
7.3 Europe CD20 Target Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CD20 Target Drug by Country
8.1.1 Middle East & Africa CD20 Target Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa CD20 Target Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa CD20 Target Drug Sales by Type
8.3 Middle East & Africa CD20 Target Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD20 Target Drug
10.3 Manufacturing Process Analysis of CD20 Target Drug
10.4 Industry Chain Structure of CD20 Target Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD20 Target Drug Distributors
11.3 CD20 Target Drug Customer
12 World Forecast Review for CD20 Target Drug by Geographic Region
12.1 Global CD20 Target Drug Market Size Forecast by Region
12.1.1 Global CD20 Target Drug Forecast by Region (2024-2029)
12.1.2 Global CD20 Target Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CD20 Target Drug Forecast by Type
12.7 Global CD20 Target Drug Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche CD20 Target Drug Product Portfolios and Specifications
13.1.3 Roche CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi CD20 Target Drug Product Portfolios and Specifications
13.2.3 Sanofi CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis CD20 Target Drug Product Portfolios and Specifications
13.3.3 Novartis CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 TG Therapeutics
13.4.1 TG Therapeutics Company Information
13.4.2 TG Therapeutics CD20 Target Drug Product Portfolios and Specifications
13.4.3 TG Therapeutics CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TG Therapeutics Main Business Overview
13.4.5 TG Therapeutics Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie CD20 Target Drug Product Portfolios and Specifications
13.5.3 AbbVie CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Genmab
13.6.1 Genmab Company Information
13.6.2 Genmab CD20 Target Drug Product Portfolios and Specifications
13.6.3 Genmab CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Genmab Main Business Overview
13.6.5 Genmab Latest Developments
13.7 PT Kalbe Genexine Biologics
13.7.1 PT Kalbe Genexine Biologics Company Information
13.7.2 PT Kalbe Genexine Biologics CD20 Target Drug Product Portfolios and Specifications
13.7.3 PT Kalbe Genexine Biologics CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 PT Kalbe Genexine Biologics Main Business Overview
13.7.5 PT Kalbe Genexine Biologics Latest Developments
13.8 Amgen, Inc.
13.8.1 Amgen, Inc. Company Information
13.8.2 Amgen, Inc. CD20 Target Drug Product Portfolios and Specifications
13.8.3 Amgen, Inc. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Amgen, Inc. Main Business Overview
13.8.5 Amgen, Inc. Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. CD20 Target Drug Product Portfolios and Specifications
13.9.3 Pfizer Inc. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Sandoz, Inc.
13.10.1 Sandoz, Inc. Company Information
13.10.2 Sandoz, Inc. CD20 Target Drug Product Portfolios and Specifications
13.10.3 Sandoz, Inc. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sandoz, Inc. Main Business Overview
13.10.5 Sandoz, Inc. Latest Developments
13.11 Celltrion, Inc.
13.11.1 Celltrion, Inc. Company Information
13.11.2 Celltrion, Inc. CD20 Target Drug Product Portfolios and Specifications
13.11.3 Celltrion, Inc. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Celltrion, Inc. Main Business Overview
13.11.5 Celltrion, Inc. Latest Developments
13.12 Biocad Medical, Inc.
13.12.1 Biocad Medical, Inc. Company Information
13.12.2 Biocad Medical, Inc. CD20 Target Drug Product Portfolios and Specifications
13.12.3 Biocad Medical, Inc. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biocad Medical, Inc. Main Business Overview
13.12.5 Biocad Medical, Inc. Latest Developments
13.13 mAbxience SA
13.13.1 mAbxience SA Company Information
13.13.2 mAbxience SA CD20 Target Drug Product Portfolios and Specifications
13.13.3 mAbxience SA CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 mAbxience SA Main Business Overview
13.13.5 mAbxience SA Latest Developments
13.14 Hetero Drugs Ltd.
13.14.1 Hetero Drugs Ltd. Company Information
13.14.2 Hetero Drugs Ltd. CD20 Target Drug Product Portfolios and Specifications
13.14.3 Hetero Drugs Ltd. CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hetero Drugs Ltd. Main Business Overview
13.14.5 Hetero Drugs Ltd. Latest Developments
13.15 Aryogen Pharmed
13.15.1 Aryogen Pharmed Company Information
13.15.2 Aryogen Pharmed CD20 Target Drug Product Portfolios and Specifications
13.15.3 Aryogen Pharmed CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Aryogen Pharmed Main Business Overview
13.15.5 Aryogen Pharmed Latest Developments
13.16 Biosidus SA
13.16.1 Biosidus SA Company Information
13.16.2 Biosidus SA CD20 Target Drug Product Portfolios and Specifications
13.16.3 Biosidus SA CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Biosidus SA Main Business Overview
13.16.5 Biosidus SA Latest Developments
13.17 Probiomed SA de CV
13.17.1 Probiomed SA de CV Company Information
13.17.2 Probiomed SA de CV CD20 Target Drug Product Portfolios and Specifications
13.17.3 Probiomed SA de CV CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Probiomed SA de CV Main Business Overview
13.17.5 Probiomed SA de CV Latest Developments
13.18 Henlius
13.18.1 Henlius Company Information
13.18.2 Henlius CD20 Target Drug Product Portfolios and Specifications
13.18.3 Henlius CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Henlius Main Business Overview
13.18.5 Henlius Latest Developments
13.19 Innovent
13.19.1 Innovent Company Information
13.19.2 Innovent CD20 Target Drug Product Portfolios and Specifications
13.19.3 Innovent CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Innovent Main Business Overview
13.19.5 Innovent Latest Developments
13.20 CHIATAI TIANOING
13.20.1 CHIATAI TIANOING Company Information
13.20.2 CHIATAI TIANOING CD20 Target Drug Product Portfolios and Specifications
13.20.3 CHIATAI TIANOING CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 CHIATAI TIANOING Main Business Overview
13.20.5 CHIATAI TIANOING Latest Developments
13.21 CASI Pharmaceuticals
13.21.1 CASI Pharmaceuticals Company Information
13.21.2 CASI Pharmaceuticals CD20 Target Drug Product Portfolios and Specifications
13.21.3 CASI Pharmaceuticals CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 CASI Pharmaceuticals Main Business Overview
13.21.5 CASI Pharmaceuticals Latest Developments
13.22 SinoCellTech
13.22.1 SinoCellTech Company Information
13.22.2 SinoCellTech CD20 Target Drug Product Portfolios and Specifications
13.22.3 SinoCellTech CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 SinoCellTech Main Business Overview
13.22.5 SinoCellTech Latest Developments
13.23 BioRay
13.23.1 BioRay Company Information
13.23.2 BioRay CD20 Target Drug Product Portfolios and Specifications
13.23.3 BioRay CD20 Target Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 BioRay Main Business Overview
13.23.5 BioRay Latest Developments
14 Research Findings and Conclusion
